SITC Archive Library

The Society for Immunotherapy of Cancer (SITC) hosted " Concurrent Session 107: Oncolytic Viruses and Intratumoral Therapies" during the SITC 2017 Annual Meeting on November 10, 2017. Available here are the presentation slides and video from the session.

Program Organizers

• Chair: Mario Sznol, MD – Yale School of Medicine
• Charlie Garnett Benson, PhD – Georgia State University
• Elizabeth A. Repasky, PhD – Roswell Park Cancer Institute

Program Summary

The Society for Immunotherapy of Cancer's (SITC) 32^nd Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy. This session presents information about treatment approaches using oncolytic viruses as well as the latest clinical data using this immunotherapy approach.

Intended Audience

The audience included U.S. and international researchers, regulators and healthcare professionals involved in cancer research and clinical care. This included, but was not limited to basic, translational and clinical researchers; postdoctoral fellows; oncologists; registered nurses; nurse practitioners; pharmacists; payers; and other allied health professionals.

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#PresentationSlides#Video#AnnualMeeting#SITC#Vaccines#AlliedHealth
#Clinician#Industry#Researcher#2017#ClinicalTrials#HeadandNeckCancers
#LungCancers#Melanoma#CombinationTherapy#Ipilimumab#Pembrolizumab